1 – 10 of 40
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
- The combination of ET-DRI and recipient risk factors is predictive of graft failure after liver transplantation within the Eurotransplant region
- Long-term safety with everolimus-based regimen in de novo liver transplant recipients: 4-year results from the extension of H2304 study
- Absence of viable HCC in the native liver is an independent protective factor of tumor recurrence after liver transplantation
- 2013
- Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring
- Expansion of memory-type CD8⁺ T cells correlates with the failure of early immunosuppression withdrawal after cadaver liver transplantation using high-dose ATG induction and rapamycin
- Anonymity and live donor transplantation
- 2011
- New classification of ELPAT for living organ donation
- Long-term follow-up and outcome of liver transplantation from anti-hepatitis C virus-positive donors: a European multicentric case-control study
- 2010
- The metabolic syndrome and New-Onset diabetes after transplantation: presumed guilty?
- 2009
- Acute Liver Transplant Rejection Upon Immunosuppression Withdrawal in a Tolerance Induction Trial: Potential Role of IFN-gamma-secreting CD8(+) T Cells